David Trudeau

1.3k total citations
29 papers, 979 citations indexed

About

David Trudeau is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Trudeau has authored 29 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cognitive Neuroscience, 8 papers in Psychiatry and Mental health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Trudeau's work include Attention Deficit Hyperactivity Disorder (7 papers), EEG and Brain-Computer Interfaces (7 papers) and Neural and Behavioral Psychology Studies (7 papers). David Trudeau is often cited by papers focused on Attention Deficit Hyperactivity Disorder (7 papers), EEG and Brain-Computer Interfaces (7 papers) and Neural and Behavioral Psychology Studies (7 papers). David Trudeau collaborates with scholars based in United States and Canada. David Trudeau's co-authors include Esther F. Freier, Rex Cannon, Jeffrey Anderson, Sean Nugent, Laura Hansen, Stephen Barton, D. Corydon Hammond, J. Christopher Perry, Paul M. Lehrer and Vincent J. Monastra and has published in prestigious journals such as Clinical Chemistry, IEEE Transactions on Power Delivery and Journal of Neuropsychiatry.

In The Last Decade

David Trudeau

27 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Trudeau United States 15 349 184 148 100 88 29 979
Ronald A. Rauch United States 18 239 0.7× 236 1.3× 238 1.6× 232 2.3× 89 1.0× 42 1.2k
Cesare Cerri Italy 20 104 0.3× 165 0.9× 131 0.9× 180 1.8× 89 1.0× 68 1.2k
Stig Hansen United Kingdom 15 159 0.5× 146 0.8× 105 0.7× 88 0.9× 125 1.4× 25 954
Yaffa Vered Israel 19 80 0.2× 221 1.2× 114 0.8× 122 1.2× 88 1.0× 32 1.0k
Tudor Phillips United Kingdom 16 233 0.7× 308 1.7× 111 0.8× 309 3.1× 39 0.4× 19 1.7k
H Asaba Japan 16 176 0.5× 219 1.2× 51 0.3× 40 0.4× 82 0.9× 56 828
Keith Robinson United States 19 182 0.5× 266 1.4× 147 1.0× 259 2.6× 23 0.3× 61 1.2k
Winston C. V. Parris United States 17 176 0.5× 149 0.8× 51 0.3× 58 0.6× 70 0.8× 64 1.1k
Chiou‐Lian Lai Taiwan 19 204 0.6× 309 1.7× 117 0.8× 154 1.5× 69 0.8× 68 1.0k
G. Ferrari Italy 21 139 0.4× 211 1.1× 86 0.6× 114 1.1× 46 0.5× 61 1.1k

Countries citing papers authored by David Trudeau

Since Specialization
Citations

This map shows the geographic impact of David Trudeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Trudeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Trudeau more than expected).

Fields of papers citing papers by David Trudeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Trudeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Trudeau. The network helps show where David Trudeau may publish in the future.

Co-authorship network of co-authors of David Trudeau

This figure shows the co-authorship network connecting the top 25 collaborators of David Trudeau. A scholar is included among the top collaborators of David Trudeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Trudeau. David Trudeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourbonnais, Anne, et al.. (2018). What to consider when developing gerontechnologies for nursing homes?. Gerontechnology. 17(s). 127–127. 2 indexed citations
2.
Bourbonnais, Anne, Jacqueline Rousseau, Jean Meunier, et al.. (2017). BEHAVIORAL SYMPTOMS AND FALLS IN LONG-TERM CARE FACILITIES: PERCEPTIONS OF GERONTECHNOLOGY. Innovation in Aging. 1(suppl_1). 287–287. 3 indexed citations
3.
Hammond, D. Corydon, et al.. (2011). Standards of Practice for Neurofeedback and Neurotherapy: A Position Paper of the International Society for Neurofeedback & Research. Journal of Neurotherapy. 15(1). 54–64. 21 indexed citations
4.
Cannon, Rex, et al.. (2008). EEG Biofeedback as a Treatment for Substance Use Disorders: Review, Rating of Efficacy, and Recommendations for Further Research. Applied Psychophysiology and Biofeedback. 33(1). 1–28. 147 indexed citations
5.
Cannon, Rex, et al.. (2008). EEG Biofeedback as a Treatment for Substance Use Disorders: Review, Rating of Efficacy and Recommendations for Further Research. Journal of Neurotherapy. 12(1). 5–43. 24 indexed citations
6.
Trudeau, David. (2005). EEG Biofeedback for Addictive Disorders—The State of the Art in 2004. Journal of Adult Development. 12(2-3). 139–146. 23 indexed citations
7.
Trudeau, David. (2005). Applicability of brain wave biofeedback to substance use disorder in adolescents. Child and Adolescent Psychiatric Clinics of North America. 14(1). 125–136. 23 indexed citations
8.
Trudeau, David, et al.. (2003). Integrating AM/FM maps with distribution SCADA. 135–140.
9.
Vaque, Theodore J. La, D. Corydon Hammond, David Trudeau, et al.. (2002). Template for Developing Guidelines for the Evaluation of the Clinical Efficacy of Psychophysiological Interventions. Journal of Neurotherapy. 6(4). 11–23. 15 indexed citations
10.
Vaque, Theodore J. La, D. Corydon Hammond, David Trudeau, et al.. (2002). Template for Developing Guidelines for the Evaluation of the Clinical Efficacy of Psychophysiological Interventions. Applied Psychophysiology and Biofeedback. 27(4). 273–281. 78 indexed citations
11.
Trudeau, David. (2002). Neurotherapy Around the World. Journal of Neurotherapy. 5(3). 1–2. 1 indexed citations
12.
Trudeau, David. (2001). Placebo and the Two Faces of Neurotherapy. Journal of Neurotherapy. 5(1-2). 1–4. 1 indexed citations
13.
Moore, John P., et al.. (2000). Comparison of Alpha-Theta, Alpha and EMG Neurofeedback in the Production of Alpha-Theta Crossover and the Occurrence of Visualizations. Journal of Neurotherapy. 4(1). 29–42. 19 indexed citations
14.
Trudeau, David, et al.. (1999). Quantitative EEG Findings Associated with Chronic Stimulant and Cannabis Abuse and ADHD in an Adult Male Substance Use Disorder Population. Clinical Electroencephalography. 30(4). 165–174. 9 indexed citations
15.
Hoffman, Daniel A., Joel F. Lubar, Robert W. Thatcher, et al.. (1999). Limitations of the American Academy of Neurology and American Clinical Neurophysiology Society Paper on QEEG. Journal of Neuropsychiatry. 11(3). 401–407. 29 indexed citations
16.
Trudeau, David. (1998). Changes in the Journal of Neurotherapy. Journal of Neurotherapy. 3(1). i–ii. 1 indexed citations
17.
Trudeau, David, et al.. (1998). Findings of Mild Traumatic Brain Injury in Combat Veterans With PTSD and a History of Blast Concussion. Journal of Neuropsychiatry. 10(3). 308–313. 135 indexed citations
18.
Trudeau, David, et al.. (1995). Efficacy of Smoking Cessation Strategies in a Treatment Program. Journal of Addictive Diseases. 14(1). 109–116. 19 indexed citations
19.
Trudeau, David. (1994). Clonazepam Prescribing Patterns and Abuse by Methadone Patients in a Medical Center Setting. Journal of Addictive Diseases. 13(2). 99–107. 11 indexed citations
20.
Trudeau, David & Esther F. Freier. (1967). Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS).. PubMed. 13(2). 101–14. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026